Indian Journal of Clinical Biochemistry

, Volume 28, Issue 1, pp 74–78 | Cite as

Vitamin D Deficiency and Insulin Resistance in Normal and Type 2 Diabetes Subjects

  • Sowjanya Bachali
  • K. Dasu
  • K. Ramalingam
  • J. N. Naidu
Original Research

Abstract

Vitamin D is recognized to serve a wide range of biological functions. The presence of vitamin D receptors on different tissues explains it’s diversity of actions. Reduced levels of vitamin D is associated with insulin resistance and increased diabetes risk. The study included 50 normal healthy individuals and 49 type 2 diabetes subjects. Fasting blood glucose, total cholesterol, triglycerides, HDLc, fasting insulin, parathyroid hormone, calcium, albumin and Homeostasis model for assessment of insulin resistance (HOMAIR) were measured in all the study participants. Type 2 diabetes subjects were divided into group 1 with 25 hydroxy vitamin D (25(OH)D) ≤20 ng/ml and group 2 with 25(OH)D >20 ng/ml. By the results of this study, the mean 25(OH)D level was low (20.09 ng/ml) in type 2 diabetes compared to controls (23.89 ng/ml) and the p value was 0.02. The estimated insulin resistance by HOMAIR was more in group 1 than in group 2 of diabetes with p value of 0.037. The Pearson’s correlation-coefficient was negative for 25(OH)D and insulin in type 2 diabetes (r = −0.294), 25(OH)D was negatively correlated with HOMAIR in total subjects. Type 2 diabetes subjects had reduced levels of vitamin D than normal individuals. The insulin resistance was more in vitamin D deficiency state. Hence vitamin D has a role in glucose metabolism, deficiency can result in insulin resistance and diabetes.

Keywords

Diabetes Insulin resistance 25 hydroxy vitamin D 

References

  1. 1.
    Kochhupalli N. The physiology of vitamin D. Indian J Med Res. 2008;127:256–62.Google Scholar
  2. 2.
    Nagapal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–7.CrossRefGoogle Scholar
  3. 3.
    Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):55–72.CrossRefGoogle Scholar
  4. 4.
    Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am. 2012;38(1):179–206.PubMedCrossRefGoogle Scholar
  6. 6.
    Paul K, Maarit L, Catharina M, Tommi H, Jukka M, H Markku, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19(5):666–71.CrossRefGoogle Scholar
  7. 7.
    Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxy vitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1(1):18–28.PubMedCrossRefGoogle Scholar
  9. 9.
    Mohan V, Sandeep S, Deepa R, Shah B, Vrghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.PubMedGoogle Scholar
  10. 10.
    Hodgkin P, Hine PM, Kay GH, Lumb GA, Stanbury SW. Vitamin D deficiency in Asians at home and in Britain. Lancet. 1973;302:167–72.CrossRefGoogle Scholar
  11. 11.
    Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol. 1995;43:351–8.CrossRefGoogle Scholar
  12. 12.
    Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxy vitamin D concentration in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472–5.PubMedGoogle Scholar
  13. 13.
    Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PVLN, Sarma KVS, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007;85:1062–7.PubMedGoogle Scholar
  14. 14.
    Harinarayan CV. Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int. 2005;16:397–402.PubMedCrossRefGoogle Scholar
  15. 15.
    Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D. Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res. 2008;127:211–8.PubMedGoogle Scholar
  16. 16.
    Harinarayan CV, Ramalakshmi T, Venkata Prasad U. High prevalence of low dietary calcium and low vitamin D status in healthy South Indians. Asia Pac J Clin Nutr. 2004;13:359–64.PubMedGoogle Scholar
  17. 17.
    Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79:820–5.PubMedGoogle Scholar
  18. 18.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. a systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.PubMedCrossRefGoogle Scholar
  19. 19.
    scragg R, Sowers M, Bell C. Serum 25-hydroxy vitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27:2813–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Ford ES, Ajani UA, McGuire LC, Liu S. Concentration of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28:1228–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Bourlon PM, Billaudel B. Dussert. Influence of Vitami D3 deficiency and 1,25 dihydroxy D3 on denovo insulin biosynthesis in islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95.PubMedCrossRefGoogle Scholar
  22. 22.
    Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Giulietti A, Van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-dihydroxy vitamin D3 works as anti inflammatory. Diabetes Res Clin Pract. 2007;77(1):47–57.PubMedCrossRefGoogle Scholar
  24. 24.
    Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti inflammatory activity of 1,25 dihydroxy vitamin D3 in macrophages. J Steroid Biochem Mol Biol. 2007;103:558–62.PubMedCrossRefGoogle Scholar
  25. 25.
    Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int. 1995;57:127–32.PubMedCrossRefGoogle Scholar
  26. 26.
    Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22:82–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Ling L, Zhijie Y, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxy vitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278–83.CrossRefGoogle Scholar
  28. 28.
    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetes subjects. Diabetes Care. 2002;25(7):135–41.CrossRefGoogle Scholar
  29. 29.
    Harinarayan CV, Joshi SR. Vitamin D status in India—its implications and remedial measures. J Assoc Physicians India. 2009;57:40–8.PubMedGoogle Scholar
  30. 30.
    Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxy vitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care. 2011;34:1133–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, et al. In situ detection of 1, 25 dihydroxy vitamin D receptor in human skeletal muscle tissue. Histochem J. 2001;33(1):19–24.PubMedCrossRefGoogle Scholar
  32. 32.
    Alvarez JA, Ashraf A. Role of Vitamin D in Insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:1–18.CrossRefGoogle Scholar
  33. 33.
    Norman AW. Vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, et al. 1α,25 Dihydroxy vitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112:122–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Ogunkolade BW, Boucher BJ, Prahl JM. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51:2294–300.PubMedCrossRefGoogle Scholar
  36. 36.
    Calle C, Maestro B. Garcia–arencibia M. Genomic actions of 1,25-dihydroxy vitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in kidney, liver and functions: VDRs, gene expression, and insulin secretion. Endocrinology. 1994;134:1602–10.CrossRefGoogle Scholar
  37. 37.
    Nita G, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline 25 hydroxy vitamin D is predictive of future glycemic status and Insulin resistance. The medical research council Ely prospective study—1990–2000. Diabetes. 2008;57(10):2619–25.CrossRefGoogle Scholar
  38. 38.
    Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin D and Insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care. 2010;33:1373–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Rathi N, Rathi A. Vitamin D and child health in the 21st century. Indian Pediatr. 2011;48:619–25.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2012

Authors and Affiliations

  • Sowjanya Bachali
    • 1
  • K. Dasu
    • 2
  • K. Ramalingam
    • 1
  • J. N. Naidu
    • 1
  1. 1.Department of BiochemistryNarayana Medical College and HospitalNelloreIndia
  2. 2.Department of Internal MedicineNarayana Medical College and HospitalNelloreIndia

Personalised recommendations